retatrutide phase 2 trial type 2 diabetes weight loss 2024 VisualAbstract: reduces body by 17.5% in patients with obesity Lilly's triple agonist achieves 16.8%

Lupus, Sjgrens, and Ankylosing Spondylitis and More GLP-1s may calm immune responses, offset steroid-induced weight gain, protect the kidneys, and lower heart disease risk

This is beyond what we see with any other medication on the market, and it is what we see with some bariatric surgeries, obesity medicine expert Jennah Siwak, MD, reported to her hundreds of thousands of followers on TikTok

For perspective on where this lands against the field (placebo-adjusted weight loss): Type 2 diabetes TRANSCEND-T2D-1 (n = 537, 40 weeks) Published simultaneously in The Lancet

It comes from your gut and helps your body process sugar in two big ways

Average weight loss in studies is helpful for understanding trends, but individuals vary

Knowing the key differences between semaglutide and tirzepatide is important for anyone who wants to switch between these medicines